HIA
IONS icon

Harbor Investment Advisory’s Ionis Pharmaceuticals IONS Stock Holding History

Harbor Investment Advisory’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+1,407
New +$106K 0.01% 530
2021
Q3 		– Sell
-38
Closed -$2K – 1333
2021
Q2 		$2K Hold
38
– – ﹤0.01% 1185
2021
Q1 		$2K Hold
38
– – ﹤0.01% 1175
2020
Q4 		$2K Hold
38
– – ﹤0.01% 1105
2020
Q3 		$2K Hold
38
– – ﹤0.01% 1026
2020
Q2 		$2K Hold
38
– – ﹤0.01% 994
2020
Q1 		$2K Hold
38
– – ﹤0.01% 935
2019
Q4 		$2K Buy
+38
New +$2.26K ﹤0.01% 772

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
CC
Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return

Harbor Investment Advisory's IONS Position: Q2 2026 in Review

Harbor Investment Advisory opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 1,407 shares worth $112K. The stake represents 0.01% of the portfolio and ranks #530 among its holdings. This is a return to the name: Harbor Investment Advisory previously reported a position in IONS as recently as Q2 2021.

Harbor Investment Advisory first reported a position in IONS in Q4 2019 and has held it in 8 quarters since. 45 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Harbor Investment Advisory held 1,407 shares of Ionis Pharmaceuticals worth $112K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Harbor Investment Advisory position in Q2 2026.
  • Ionis Pharmaceuticals made up 0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #530 holding.
  • Harbor Investment Advisory first reported a position in Ionis Pharmaceuticals in Q4 2019 and has held it in 8 quarters since.
  • 45 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.